| [1] Guttmann E, Guttmann L, Medawar PB, et al. The rate of regeneration of nerve. Br Med Bull. 1943;19(7):14-44.[2] Al-Majed AA, Brushart TM, Gordon T. Electrical stimulation accelerates and increases expression of BDNF and trkB mRNA in regenerating rat femoral motoneurons. Eur J Neurosci. 2000;12(12):4381-4390.[3] Sulaiman OA, Gordon T. Role of chronic Schwann cell denervation in poor functional recovery after nerve injuries and experimental strategies to combat it. Neurosurgery. 2009;65(4 Suppl):A105-114.[4] 徐建广,顾玉东,李继峰.大鼠失神经支配骨骼肌及其运动终板退变观察[J].中华显微外科杂志,1999,22(3):215.[5] Adams L, Carlson BM, Henderson L, et al. Adaptation of nicotinic acetylcholine receptor, myogenin, and MRF4 gene expression to long-term muscle denervation. J Cell Biol. 1995;131(5):1341-1349.[6] Yang D, Biragyn A, Kwak LW, et al. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 2002;23(6):291-296.[7] Verbanac D, Zanetti M, Romeo D. Chemotactic and protease-inhibiting activities of antibiotic peptide precursors. FEBS Lett. 1993;317(3):255-258.[8] Duits LA, Ravensbergen B, Rademaker M, et al. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology. 2002;106(4): 517-525.[9] Nozdrachev AD, Kolosova LI, Moiseeva AB, et al. The role of defensin NP-1 in restoring the functions of an injured nerve trunk. Neurosci Behav Physiol. 2006;36(3):313-315.[10] Lindsay RM. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci. 1988;8(7):2394-2405.[11] Zhang P, Xue F, Kou Y, et al. The experimental study of absorbable chitin conduit for bridging peripheral nerve defect with nerve fasciculu in rats. Artif Cells Blood Substit Immobil Biotechnol. 2008;36(4):360-371. [12] Bhisitkul RB, Villa JE, Kocsis JD. Axonal GABA receptors are selectively present on normal and regenerated sensory fibers in rat peripheral nerve. Exp Brain Res. 1987;66(3):659-663.[13] Coronas V, Durand M, Chabot JG, et al. Acetylcholine induces neuritic outgrowth in rat primary olfactory bulb cultures. Neuroscience. 2000;98(2):213-219.[14] Udina E, Ceballos D, Gold BG, et al. FK506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers. Exp Neurol. 2003;183(1):220-231.[15] Sulaiman OA, Voda J, Gold BG, et al. FK506 increases peripheral nerve regeneration after chronic axotomy but not after chronic schwann cell denervation. Exp Neurol. 2002; 175(1):127-137.[16] Bai LL, Yin WB, Chen YH, et al. A new strategy to produce a defensin: stable production of mutated NP-1 in nitrate reductase-deficient Chlorella ellipsoidea. PLoS One. 2013; 8(1):e54966.[17] Ganz T, Selsted ME, Szklarek D, et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985; 76(4):1427-1435.[18] García JR, Jaumann F, Schulz S, et al. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 2001;306(2): 257-264.[19] García JR, Krause A, Schulz S, et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 2001;15(10):1819-1821.[20] McKerracher L, David S, Jackson DL, et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 1994;13(4):805-811.[21] Fernandez-Valle C, Bunge RP, Bunge MB. Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration. J Neurocytol. 1995;24(9):667-679.[22] Rotshenker S. Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease. J Mol Neurosci. 2003;21(1):65-72.[23] Chaly YV, Paleolog EM, Kolesnikova TS, et al. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur Cytokine Netw. 2000; 11(2):257-266.[24] Kota S, Sabbah A, Chang TH, et al. Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus. J Biol Chem. 2008;283(33):22417-22429. [25] Misuno NI, Kolesnikova TS, Lerer RI, et al. Effects of human defensin HNP-1 on the production of tumor necrosis factor-alpha by human blood monocytes in vitro. Biull Eksp Biol Med. 1992;113(5):524-527. [26] Leeyaphan C, Hau C, Takeoka S, et al. Immune response in human chromoblastomycosis and eumycetoma - focusing on human interleukin-17A, interferon-gamma, tumour necrosis factor-alpha, interleukin-1 beta and human beta-defensin-2. Mycoses. 2016. in press. [27] Huang FC. The differential effects of 1,25-dihydroxyvitamin D3 on Salmonella-induced interleukin-8 and human beta-defensin-2 in intestinal epithelial cells. Clin Exp Immunol. 2016;185(1): 98-106. [28] Tokunaga H, Saito S, Sakai K, et al. Halophilic beta-lactamase as a new solubility- and folding-enhancing tag protein: production of native human interleukin 1alpha and human neutrophil alpha-defensin. Appl Microbiol Biotechnol. 2010; 86(2):649-658.[29] Décanis N, Savignac K, Rouabhia M. Farnesol promotes epithelial cell defense against Candida albicans through Toll-like receptor 2 expression, interleukin-6 and human beta-defensin 2 production. Cytokine. 2009;45(2):132-140.[30] Jang BC, Lim KJ, Suh MH, et al. Dexamethasone suppresses interleukin-1beta-induced human beta-defensin 2 mRNA expression: involvement of p38 MAPK, JNK, MKP-1, and NF-kappaB transcriptional factor in A549 cells. FEMS Immunol Med Microbiol. 2007;51(1):171-184. [31] Jang BC, Lim KJ, Choi IH, et al. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells. Int J Mol Med. 2007;19(5):757-763.[32] Derradjia A, Alanazi H, Park HJ, et al. α-tocopherol decreases interleukin-1β and -6 and increases human β-defensin-1 and -2 secretion in human gingival fibroblasts stimulated with Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res. 2016;51(3):295-303.[33] Bogaczewicz J, Malinowska K, Sysa-Jedrzejowska A, et al. Medium-dose ultraviolet A1 phototherapy improves SCORAD index and increases mRNA expression of interleukin-4 without direct effect on human β defensin-1, interleukin-10, and interleukin-31. Int J Dermatol. 2016;55(7):e380-385.[34] Shimizu T, To M, Kamata Y, et al. Human β-defensin-2 and interleukin-1β expression in response to Porphyromonas gingivalis challenge in mice transplanted with periodontitic human gingiva. Microb Pathog. 2017;107:38-43.[35] Shamash S, Reichert F, Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci. 2002; 22(8):3052-3060. [36] Kiguchi N, Maeda T, Kobayashi Y, et al. Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation. Pain. 2010;149(2):305-315.[37] Mirski R, Reichert F, Klar A, et al. Granulocyte macrophage colony stimulating factor (GM-CSF) activity is regulated by a GM-CSF binding molecule in Wallerian degeneration following injury to peripheral nerve axons. J Neuroimmunol. 2003;140(1-2):88-96. [38] Cheepudomwit T, Güzelsu E, Zhou C, et al. Comparison of cytokine expression profile during Wallerian degeneration of myelinated and unmyelinated peripheral axons. Neurosci Lett. 2008;430(3):230-235.[39] Katz Y, Nadiv O, Beer Y. Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes. Arthritis Rheum. 2001;44(9):2176-2184.[40] Perrin FE, Lacroix S, Avilés-Trigueros M, et al. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain. 2005;128(Pt 4):854-866.[41] Ichinose M, Asai M, Imai K, et al. Enhancement of phagocytosis by corticostatin I (CSI) in cultured mouse peritoneal macrophages. Immunopharmacology. 1996; 35(2):103-109.[42] Ichinose M, Sawada M. A flow cytometric assay reveals a suppression of phagocytosis by rabbit defensin NP-3A in mouse peritoneal macrophages. Microbiol Immunol. 1995; 39(5):365-367.[43] Ichinose M, Asai M, Sawada M. Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages. J Neuroimmunol. 1995;60(1-2):37-43.[44] Ichinose M, Asai M, Sawada M. beta-Endorphin enhances phagocytosis of latex particles in mouse peritoneal macrophages. Scand J Immunol. 1995;42(3):311-316.[45] Ichinose M, Hara N, Sawada M, et al. A flow cytometric assay reveals an enhancement of phagocytosis by platelet activating factor in murine peritoneal macrophages. Cell Immunol. 1994;156(2):508-518.[46] Ichinose M, Sawada M, Maeno T. Suppression of phagocytosis by adrenocorticotropic hormone in murine peritoneal macrophages. Immunol Lett. 1994;42(3):161-165. [47] Petrov V, Funderburg N, Weinberg A, et al. Human β defensin-3 induces chemokines from monocytes and macrophages: diminished activity in cells from HIV-infected persons. Immunology. 2013;140(4):413-420. [48] Barabas N, Röhrl J, Holler E, et al. Beta-defensins activate macrophages and synergize in pro-inflammatory cytokine expression induced by TLR ligands. Immunobiology. 2013; 218(7):1005-1011. [49] Ann SJ, Chung JH, Park BH, et al. PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1. Atherosclerosis. 2015;240(2):389-397. [50] Terkawi MA, Takano R, Furukawa A, et al. Involvement of β-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparum. Sci Rep. 2017;7:41772. [51] Lyu J, Bian T, Chen B, et al. β-defensin 3 modulates macrophage activation and orientation during acute inflammatory response to Porphyromonas gingivalis lipopolysaccharide. Cytokine. 2017;92:48-54. [52] Ganz T, Liu L, Valore EV, et al. Posttranslational processing and targeting of transgenic human defensin in murine granulocyte, macrophage, fibroblast, and pituitary adenoma cell lines. Blood. 1993;82(2):641-650.[53] Kawsar HI, Weinberg A, Hirsch SA, et al. Overexpression of human beta-defensin-3 in oral dysplasia: potential role in macrophage trafficking. Oral Oncol. 2009;45(8):696-702. [54] García JR, Jaumann F, Schulz S, et al. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 2001;306(2): 257-264. |
.jpg)
.jpg)
.jpg)